International Private Wealth Advisors LLC Increases Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

International Private Wealth Advisors LLC increased its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 14.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 14,730 shares of the pharmacy operator’s stock after purchasing an additional 1,870 shares during the period. International Private Wealth Advisors LLC’s holdings in Walgreens Boots Alliance were worth $137,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of WBA. Charles Schwab Investment Management Inc. lifted its position in Walgreens Boots Alliance by 43.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock valued at $98,284,000 after acquiring an additional 3,329,857 shares during the last quarter. Altrius Capital Management Inc raised its stake in Walgreens Boots Alliance by 76.6% in the third quarter. Altrius Capital Management Inc now owns 440,483 shares of the pharmacy operator’s stock valued at $3,947,000 after buying an additional 190,996 shares during the last quarter. Swedbank AB boosted its holdings in Walgreens Boots Alliance by 45.3% in the fourth quarter. Swedbank AB now owns 595,828 shares of the pharmacy operator’s stock worth $5,559,000 after acquiring an additional 185,762 shares in the last quarter. PNC Financial Services Group Inc. grew its stake in shares of Walgreens Boots Alliance by 23.4% during the third quarter. PNC Financial Services Group Inc. now owns 340,431 shares of the pharmacy operator’s stock worth $3,050,000 after acquiring an additional 64,586 shares during the last quarter. Finally, Sasco Capital Inc. CT increased its holdings in shares of Walgreens Boots Alliance by 13.6% during the third quarter. Sasco Capital Inc. CT now owns 1,041,440 shares of the pharmacy operator’s stock valued at $9,331,000 after acquiring an additional 124,950 shares in the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have weighed in on WBA shares. Jefferies Financial Group dropped their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research report on Wednesday, October 23rd. Evercore ISI boosted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a report on Monday, January 13th. UBS Group raised their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. Barclays increased their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, October 16th. Finally, Royal Bank of Canada upped their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $13.19.

View Our Latest Stock Analysis on WBA

Walgreens Boots Alliance Stock Down 1.5 %

WBA stock opened at $9.97 on Tuesday. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $22.96. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The company’s 50-day simple moving average is $10.22 and its 200-day simple moving average is $9.80.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. Walgreens Boots Alliance’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.66 earnings per share. As a group, equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Articles

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.